Patients under consideration for lung transplantation as treatment for end-stage lung diseases such as idiopathic pulmonary fibrosis (IPF) often have risk factors such as a history of smoking or concomitant emphysema. both of which can predispose the patient to lung cancer. In fact. IPF itself increases the risk of lung cancer development by 6. https://www.itsmajorlook.com/